Presentation ACC 2018 The ODYSSEY OUTCOMES Trial: Topline Results Alirocumab in Patients After Acute Coronary Syndrome Presenter: Philippe Gabriel Steg March 10, 2018
News Conference News ACC 2018 ODYSSEY Delivers a Win for Alirocumab in ACS, With a Signal of Survival Benefit Michael O'Riordan March 10, 2018
News Conference News RUBY-1: Yet Another Novel Anticoagulant Tested in ACS Patients on Antiplatelets August 31, 2011